MD Biosciences
MD Biosciences is an industry-leading provider of preclinical, translational and clinical-phase contract research services for the development of pharmaceutical and diagnostic assets. Established in 1991, MD Biosciences offers expertise, services and products across a wide range of therapeutic areas including inflammatory diseases, autoimmunity, neurology, oncology, metabolism, and pain. We collaborate with companies of all sizes, from small start-ups to large pharmaceutical pioneers, for the development of innovative therapeutics and diagnostic assays.
